Synata Bio Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 22
Employees
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $30M
Latest Deal Amount
  • Investors
  • 1

Synata Bio General Information

Description

Developer of a fermentation technology designed to process synthesis gas from multiple sources into products. The company's technology is a non-GMO biocatalyst that harmonizes all feedstocks with carbon utilization and an efficient gas-to-liquids platform, enabling users to have access to a sustainable technology to produce primary alcohols.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Machinery (B2B)
Other Industries
Other Chemicals and Gases
Primary Office
  • 4575 Weaver Parkway
  • Suite 100
  • Warrenville, IL 60555
  • United States
+1 (312) 000-0000

Synata Bio Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Synata Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 30-Jan-2018 $30M 0000 Completed Stealth
1. Early Stage VC (Series A) 11-Apr-2017 0000 0000 Completed Stealth
To view Synata Bio’s complete valuation and funding history, request access »

Synata Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00.00 00 00 00 00 000
To view Synata Bio’s complete cap table history, request access »

Synata Bio Executive Team (3)

Name Title Board Seat Contact Info
Jeremy Patt Chief Technology Officer
Steven Kloos Ph.D President & Board Member
To view Synata Bio’s complete executive team members history, request access »

Synata Bio Board Members (3)

Name Representing Role Since
Jay Kouba Ph.D True North Venture Partners Board Member 000 0000
Matthew Ahearn True North Venture Partners Board Member 000 0000
Steven Kloos Ph.D Self President & Board Member 000 0000
To view Synata Bio’s complete board members history, request access »

Synata Bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Synata Bio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
True North Venture Partners Venture Capital Minority 000 0000 000000 0
To view Synata Bio’s complete investors history, request access »

Synata Bio Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 000000000 05-Dec-2016 000000000000000000 000.00 Energy Production
Abengoa Bioenergy Biomass (Hugoton cellulosic ethanol plant) 30-Nov-2016 Corporate Asset Purchase 000.00 Buildings and Property
To view Synata Bio’s complete investments and acquisitions history, request access »